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Purpose
Hypnotherapy has been shown to be an effective treat-
ment for some conditions such as pain, anxiety, che-
motherapy side effects, and hot flashes. Measurement of
hypnotizability is essential for research. There are a
number of scales that have been developed to measure
hypnotizbility in clincal research. However, the currently
available scales suffer from a number of important
shortcomings such as time for administration, validity
concerns, and item difficulty. As a result, hypnotizability
is rarely measured in clinical work and research has
been limited. The purpose of this study was to develop
a new scale to measure hypnotizability that met the fol-
lowing criteria: (1) administration in 30 minutes or less;
(2) correlation of .80 or better with the Stanford Hypno-
tic Susceptibility Scale; and (3) improved item selection.
Methods
A 12 item hypnotizability scale (Elkins Hypnotizability
Scale; EHS) was developed with the wording for each
item based upon the clinical experience of the Principal
Investigator from administration of the EHS in clinical
work and receiving feedback from patients and expert
reviewers.
Results
The average time for administration was 27 minutes.
Test-retest reliability was r = .93. The correlation
between the EHS and the Stanford Hypnotic Suscept-
ibility Scale-Form C was r = .91.
Conclusion
Results support the development of an improved scale to
measure hypnotizability. The results demonstrated that
the scale can be administered within 30 minutes (as com-
pared to 75 minutes for the Stanford Hypnotic Susceptibil-
ity Scale-Form C). In addition, the scale demonstrated
strong reliability. The correlation between the EHS and
Stanford Hypnotic Susceptibility Scale-Form C was also
strong and significant, suggesting that the EHS measures
the same domain of hypnotic responding and is therefore
likely to be a valid measure. The present study reports on
initial scale development, and the utility of the EHS in
clinical research is presently being determined.
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